Explore our comprehensive coverage of pharmacology, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA has qualified its first AI tool for clinical trials in 2026, validating the use of multimodal models and digital twins for patient stratificat...
Read Full Story →
GadgetsGLP-1 medications in 2026 are transforming from weight-loss drugs to essential cardiovascular and re...
HealthcareThe FDA has approved the first daily oral, non-peptide GLP-1 receptor agonist, shattering the inject...
HealthThe FDA has approved MDMA-assisted psychotherapy for severe PTSD based on Phase 3 MAPS trial data. T...
